Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 May 2024 | Story Carmenita Redcliffe-Paul
Global Citizen

The University of the Free State (UFS) and the South African Chamber of Commerce United Kingdom (SACC UK) are pleased to present a Global Citizen Series conversation, Exploring Scenarios: South Africa’s Democracy in the face of the next general elections, from the perspective of Clem Sunter, international best-selling author, futurologist, and scenario planner. 

As part of the Global Citizen Webinar Series, international scenario planner and futurologist, Clem Sunter, will join UFS Vice-Chancellor and Principal, Prof Francis Petersen, and SACC UK Chairperson, Sharon Constançon, for a conversation that answers the question – What does the future hold for South Africa’s democracy in the face of the upcoming general elections?

Thirty years ago, the majority of South Africans won the right to vote for the first time, leading to South Africa’s first democratic elections in 1994. Join us for a conversation on 20 May 2024 as we explore scenarios depicted by Clem Sunter ahead of South Africa’s seventh general elections scheduled for 29 May 2024.

Join the Global conversation for Global Citizens

Date:  Monday, 20 May 2024
SA time: 15:00-16:00 / UK time: 14:00-15:00
The livestream link will be shared with those who RSVP
Enquiries: Tebello Leputla - leputlatb@ufs.ac.za +27 51 401 9199

About Clem Sunter

Clem Sunter, born in Suffolk England on 8 August 1944, gained his education at Winchester College. Before joining Charter Consolidated as a management trainee in 1966, he went to Oxford where he read politics, philosophy, and economics.

He moved to Lusaka in Zambia to work for the Anglo-American Corporation Central Africa in 1971. He then transferred to the head office of the Anglo-American Corporation of South Africa in Johannesburg in 1973. He spent most of his succeeding career in the Gold and Uranium Division, where he served as chairman and CEO from 1990 to 1996. During this time, Anglo-American was the largest producer of gold in the world. Until recently he was chairman of the Anglo-American Chairman’s Fund, which was – as stated in a recent survey – the primary corporate social responsibility fund in South Africa. Read more about Clem Sunter.

News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk.
Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept